PL3227271T3 - Heterocykliczne pochodne i ich zastosowanie - Google Patents

Heterocykliczne pochodne i ich zastosowanie

Info

Publication number
PL3227271T3
PL3227271T3 PL15865425.1T PL15865425T PL3227271T3 PL 3227271 T3 PL3227271 T3 PL 3227271T3 PL 15865425 T PL15865425 T PL 15865425T PL 3227271 T3 PL3227271 T3 PL 3227271T3
Authority
PL
Poland
Prior art keywords
heterocyclic derivatives
heterocyclic
derivatives
Prior art date
Application number
PL15865425.1T
Other languages
English (en)
Inventor
Chan Hee Park
Sang Hwi Lee
Junhwan IM
Soon Ok Lee
Jungsook Kim
Heon Kyu Park
Jee Hun YUN
Kwang Seok Ko
Hye Jung Kim
Byungho Kim
Mi Sun Kim
Minjung KONG
Hyung Jo MOON
Original Assignee
C&C Research Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C&C Research Laboratories filed Critical C&C Research Laboratories
Priority claimed from PCT/KR2015/012926 external-priority patent/WO2016089062A2/en
Publication of PL3227271T3 publication Critical patent/PL3227271T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
PL15865425.1T 2014-12-02 2015-11-30 Heterocykliczne pochodne i ich zastosowanie PL3227271T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20140170860 2014-12-02
KR1020150128025A KR20160066490A (ko) 2014-12-02 2015-09-10 헤테로사이클 유도체 및 그의 용도
PCT/KR2015/012926 WO2016089062A2 (en) 2014-12-02 2015-11-30 Heterocyclic derivatives and use thereof

Publications (1)

Publication Number Publication Date
PL3227271T3 true PL3227271T3 (pl) 2025-11-12

Family

ID=56092629

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15865425.1T PL3227271T3 (pl) 2014-12-02 2015-11-30 Heterocykliczne pochodne i ich zastosowanie

Country Status (18)

Country Link
US (2) US10633394B2 (pl)
EP (2) EP3227271B1 (pl)
JP (2) JP6640222B2 (pl)
KR (3) KR20160066490A (pl)
CN (2) CN107001345B (pl)
AU (2) AU2015355841B2 (pl)
BR (1) BR112017011316B1 (pl)
CA (2) CA2966742A1 (pl)
ES (2) ES2993440T3 (pl)
IL (1) IL252560B (pl)
MX (2) MX382261B (pl)
MY (1) MY194314A (pl)
PH (2) PH12021550305A1 (pl)
PL (1) PL3227271T3 (pl)
RU (2) RU2711502C2 (pl)
SG (1) SG11201703296PA (pl)
TW (2) TWI691484B (pl)
WO (1) WO2016089060A2 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7114394B2 (ja) * 2017-08-18 2022-08-08 住友化学株式会社 化合物、レジスト組成物及びレジストパターンの製造方法
CN107973788B (zh) * 2018-01-09 2021-07-09 沈阳药科大学 Bbi608衍生物及其制备与用途
CN109045013A (zh) * 2018-06-20 2018-12-21 新乡医学院第附属医院 Nifuroxazide的医药新用途
CN120574283A (zh) 2019-04-05 2025-09-02 凯麦拉医疗公司 Stat降解剂和其用途
KR102426921B1 (ko) * 2019-09-24 2022-07-29 주식회사 이노보테라퓨틱스 헤테로아릴아미도피리딘올 유도체 및 이를 유효성분으로 포함하는 자가면역질환의 예방 또는 치료용 약학적 조성물
EP4048664A1 (en) 2019-10-25 2022-08-31 Gilead Sciences, Inc. Glp-1r modulating compounds
WO2021100942A1 (ko) * 2019-11-22 2021-05-27 재단법인 한국파스퇴르연구소 항결핵 화합물인 티에노싸이아졸카박사아마이드 유도체
EP4085059B1 (en) * 2020-01-02 2024-03-20 Accro Bioscience (HK) Limited Heteroaryl compounds as inhibitors of programmed necrosis pathway, composition and method using the same
CN113150009B (zh) * 2020-01-07 2023-05-23 爱科诺生物医药(香港)有限公司 一类具有程序性细胞坏死通路抑制活性的杂环化合物及其应用
ES3016132T3 (en) 2020-01-29 2025-05-08 Gilead Sciences Inc Glp-1r modulating compounds
EP4247804A1 (en) 2020-11-20 2023-09-27 Gilead Sciences, Inc. Polyheterocyclic glp-1 r modulating compounds
EP4304712A1 (en) 2021-03-11 2024-01-17 Gilead Sciences, Inc. Glp-1r modulating compounds
WO2022192428A1 (en) 2021-03-11 2022-09-15 Gilead Sciences, Inc. Glp-1r modulating compounds
IL306110A (en) 2021-04-21 2023-11-01 Gilead Sciences Inc Carboxy-benzimidazole glp-1r modulating compounds
WO2025046475A1 (ko) * 2023-08-29 2025-03-06 제이더블유중외제약 주식회사 아토피성 피부염 치료용 헤테로환형 유도체
WO2025120552A1 (ko) * 2023-12-07 2025-06-12 제이더블유중외제약 주식회사 헤테로사이클 유도체 함유 고체분산체, 이의 제조 방법, 이를 포함하는 약학적 조성물
WO2025120550A1 (ko) * 2023-12-08 2025-06-12 제이더블유중외제약 주식회사 헤테로사이클 유도체 제조에 사용되는 중간체 화합물, 이의 제조 방법 및 이를 이용한 헤테로사이클 유도체의 제조 방법
WO2025120551A1 (ko) * 2023-12-08 2025-06-12 제이더블유중외제약 주식회사 헤테로사이클 유도체 제조에 사용되는 중간체 화합물, 이의 제조 방법 및 이를 이용한 헤테로사이클 유도체의 제조 방법
WO2025180442A1 (zh) * 2024-03-01 2025-09-04 贝达药业股份有限公司 Hdac抑制剂及其在医药上的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210090A (en) 1989-09-05 1993-05-11 G. D. Searle & Co. Substituted N-benzylpiperidine amides and cardiac regulatory compositions thereof
GB9215361D0 (en) 1992-07-20 1992-09-02 Wellcome Found Heterocyclic compounds
TW404834B (en) * 1994-08-22 2000-09-11 Lilly Co Eli Pharmaceutical compositions for inhibiting endometrial cancer
DE69719544T2 (de) * 1996-12-12 2003-11-06 Banyu Pharmaceutical Co., Ltd. Pyrazolderivate
EP1470119A4 (en) 2001-06-13 2005-10-19 Genesoft Pharmaceuticals Inc BENZOTHIOPHENE COMPOUNDS WITH ANTI-INFECTIOUS ACTIVITY
AU2003265382A1 (en) 2002-08-23 2004-03-11 Pharmacia & Upjohn Company Llc Antibacterial benzoic acid derivatives
US20060142271A1 (en) * 2002-09-17 2006-06-29 Klaus Muller Novel lapacho compounds and methods of use thereof
EP1692124B1 (en) * 2003-12-04 2008-10-15 Wyeth Biaryl sulfonamides as mmp inhibitors
EP1598353A1 (en) * 2004-05-17 2005-11-23 Boehringer Ingelheim International GmbH Pyrrolobenzimidazolones and their use as antiproliferative agents
JP5301999B2 (ja) * 2005-10-31 2013-09-25 メルク・シャープ・アンド・ドーム・コーポレーション Cetp阻害薬
UA95978C2 (ru) * 2006-10-02 2011-09-26 Оцука Фармас'Ютікел Ко., Лтд. Ингибитор активации stat3/5
WO2008124000A2 (en) 2007-04-02 2008-10-16 Ligand Pharmaceuticals Incorporated Thiazole derivatives as androgen receptor modulator compounds
HRP20160625T1 (hr) * 2007-09-10 2016-08-12 Boston Biomedical, Inc. Novi inhibitori stat3 signalnog puta i inhibitori matičnih stanica raka
US8466290B2 (en) * 2008-07-10 2013-06-18 Pharma Ip General Incorporated Association STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient
EP2430015B1 (en) 2009-05-12 2015-06-17 Merck Sharp & Dohme Corp. Fused tricyclic compounds useful for the treatment of viral diseases
JP2012529518A (ja) * 2009-06-09 2012-11-22 アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー ヘッジホッグシグナル伝達のピリジル−トリアジン阻害剤
EP3103452A1 (en) * 2009-08-25 2016-12-14 Abraxis BioScience, LLC Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors
EP2794592A1 (en) * 2011-12-23 2014-10-29 Novartis AG Compounds for inhibiting the interaction of bcl2 with binding partners
WO2014196793A1 (en) * 2013-06-05 2014-12-11 C&C Research Laboratories Heterocyclic derivatives and use thereof
US10167257B2 (en) * 2014-04-04 2019-01-01 Iomet Pharma Ltd. Indole derivatives for use in medicine

Also Published As

Publication number Publication date
MY194314A (en) 2022-11-28
US20190119297A1 (en) 2019-04-25
CN107001345A (zh) 2017-08-01
EP3227271A2 (en) 2017-10-11
BR112017011312A2 (pt) 2018-01-02
BR112017011316A2 (pt) 2018-01-02
US10023591B2 (en) 2018-07-17
SG11201703296PA (en) 2017-05-30
KR20160066490A (ko) 2016-06-10
IL252560B (en) 2021-04-29
EP3227270A2 (en) 2017-10-11
WO2016089060A3 (en) 2016-08-25
ES2993440T3 (en) 2024-12-30
TW201629012A (zh) 2016-08-16
CN107231802A (zh) 2017-10-03
RU2711502C2 (ru) 2020-01-17
JP2017537110A (ja) 2017-12-14
BR112017011316B1 (pt) 2023-12-26
AU2015355839B2 (en) 2020-01-16
MX381911B (es) 2025-03-13
AU2015355839A1 (en) 2017-05-25
CA2966759C (en) 2024-01-23
MX382261B (es) 2025-03-13
US10633394B2 (en) 2020-04-28
MX2017006224A (es) 2017-07-31
PH12021550305A1 (en) 2023-03-13
AU2015355841A1 (en) 2017-06-22
RU2017123170A (ru) 2019-01-09
PH12017550004A1 (en) 2017-10-18
KR20170081708A (ko) 2017-07-12
MX2017006165A (es) 2017-07-19
CN107001345B (zh) 2021-03-02
RU2734390C2 (ru) 2020-10-15
PH12017550004B1 (en) 2021-12-15
CA2966742A1 (en) 2016-06-09
EP3227271A4 (en) 2018-05-30
JP2017537111A (ja) 2017-12-14
KR102534262B1 (ko) 2023-05-19
JP6640222B2 (ja) 2020-02-05
US20170320889A1 (en) 2017-11-09
EP3227270A4 (en) 2018-06-06
WO2016089060A2 (en) 2016-06-09
KR20170081707A (ko) 2017-07-12
KR102534266B1 (ko) 2023-05-19
IL252560A0 (en) 2017-07-31
ES3049340T3 (en) 2025-12-16
TWI691484B (zh) 2020-04-21
NZ731847A (en) 2021-11-26
EP3227270B1 (en) 2024-11-13
TW201632529A (zh) 2016-09-16
TWI687423B (zh) 2020-03-11
RU2017120973A (ru) 2019-01-09
RU2017123170A3 (pl) 2019-04-19
JP6648137B2 (ja) 2020-02-14
EP3227271C0 (en) 2025-08-13
RU2017120973A3 (pl) 2019-04-08
CN107231802B (zh) 2021-02-12
EP3227271B1 (en) 2025-08-13
CA2966759A1 (en) 2016-06-09
AU2015355841B2 (en) 2019-12-19

Similar Documents

Publication Publication Date Title
IL279663A (en) N4-hydroxycytidine, history and related antiviral uses
IL252560A0 (en) Heterocyclic derivatives and their uses
IL258180B (en) Heterocyclic compounds and their uses
IL258081B (en) Benzimidazole history and their use
IL247252B (en) History of isoquinoline and its use
IL253656A0 (en) Mono- and polyazanephthalene modified histories and their use
EP3099171A4 (en) Dihydropteridinone derivatives and uses thereof
ZA201703768B (en) Fgf21 derivatives and uses thereof
IL259150B (en) Pyrimidine derivative and use thereof
EP3154972A4 (en) Azamophinan derivatives and use thereof
EP3154971A4 (en) Heterocyclic morphinan derivatives and use thereof
IL257283A (en) Chiral phosphoramidates and their history
EP3177147A4 (en) Dihydropteridinone derivatives and uses thereof
EP3197885A4 (en) Heterocyclic compounds and use thereof
ZA201701066B (en) Pyridine derivatives and anti-mycobacterial use thereof
HUE048394T2 (hu) Új triazolopirimidinon vagy triazolopyridinone származékok és ezek felhasználása
PL3162804T3 (pl) Nowa pochodna benzodiazepiny i jej zastosowanie
SG11201605915WA (en) Furo-3-carboxamide derivatives and methods of use
IL251335A0 (en) Piperidinylpyrazolopyrimidinones and their use
ZA201607919B (en) Dipicolylamine derivatives and their pharmaceutical uses
PL3268356T3 (pl) Związki heterocykliczne i sposoby ich stosowania
GB201416351D0 (en) Heterocyclic derivatives
PL3229772T3 (pl) 6-arylo-9-glikozylopuryny i ich zastosowanie
AU2014901768A0 (en) Heterocyclic compounds and use of same